Gene Amplification Technologies Market Size, Share, Growth Analysis, By Technology(PCR, NASBA, LAMP, and others), By End user(Academic & research institutions, diagnostic labs, and pharmaceutical companies), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2150 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 64 |Figures: 75

Gene Amplification Technologies Market Insights

Global Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, at a CAGR of 10% during the forecast period (2024-2031).

The global gene amplification technologies market is experiencing robust growth due to advancements in molecular biology and diagnostics. Key drivers include increasing applications in disease diagnosis, personalized medicine, and biotechnology research. Polymerase chain reaction (PCR) and isothermal amplification techniques dominate the market, with CRISPR-based amplification gaining traction.

North America holds a significant market share, fueled by strong R&D activities and healthcare infrastructure. Asia-Pacific displays rapid expansion due to rising healthcare expenditure and technological adoption. As genomics continues to shape medical and research landscapes, the gene amplification technologies market is poised for sustained expansion.

US Gene Amplification Technologies Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 3.96 billion

Largest Segment

pharmaceutical companies

Fastest Growth

diagnostic labs

Growth Rate

10% CAGR

Global gene amplification technologies market by region
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Gene Amplification Technologies Market Segmental Analysis

The global gene amplification technologies market can be segmented based on technology, end-user, and region. Technological segments include PCR, NASBA, LAMP, and others. End-users involve academic & research institutions, diagnostic labs, and pharmaceutical companies. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Gene Amplification Technologies Market Analysis By Technology

Polymerase Chain Reaction (PCR) has historically been the largest segment in the gene amplification technologies market. It has a wide range of applications in research, diagnostics, forensics, and biotechnology. Real-time PCR (qPCR) and digital PCR (dPCR) have gained substantial adoption due to their quantitative capabilities. The fastest-growing segment could vary based on industry trends and technological advancements. Isothermal amplification techniques like loop-mediated isothermal amplification (LAMP) have gained popularity due to their simplicity, rapid results, and application in point-of-care diagnostics. These techniques eliminate the need for complex thermal cycling, making them suitable for resource-limited settings.

Gene Amplification Technologies Market Analysis By End-User

Biotech and pharmaceutical companies have been one of the largest and most significant end users of gene amplification technologies. These companies utilize these technologies for drug discovery, target identification, and molecular diagnostics. The demand for personalized medicine and targeted therapies has driven the adoption of gene amplification technologies in this sector.

The application of gene amplification technologies in clinical diagnostics has been growing steadily. Polymerase Chain Reaction (PCR) and other amplification techniques are commonly used for diagnosing genetic diseases, identifying pathogens, and detecting specific genetic markers associated with diseases. The need for accurate and rapid diagnostics has contributed to the growth of this segment.

Global gene amplification technologies market by end user

To get detailed analysis on other segments, Request For Free Sample Report

Gene Amplification Technologies Market Regional Insights

North America and Europe were likely the largest markets for gene amplification technologies due to their established biotechnology industries, extensive R&D capabilities, and supportive regulatory frameworks. These regions have a long history of innovation in the life sciences and biotechnology sectors.

The Asia-Pacific region was considered one of the fastest-growing regions. This growth could be attributed to factors such as increasing investments in research and development, a growing number of biotech startups, and rising awareness about advanced medical technologies.

Global gene amplification technologies market by Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Gene Amplification Technologies Market Dynamics

Gene Amplification Technologies Market Drivers

Demand for Personalized Medicines

  • The increasing demand for personalized medicine and advancements in biotechnology are propelling the growth of the global gene amplification technologies market, as these technologies enable accurate and efficient analysis of genetic material for diagnostic and research purposes.

Gene Amplification Technologies Market Restraints

Ethical Concerns

  • Ethical concerns surrounding genetic manipulation, complex regulatory frameworks, and high costs associated with gene amplification technologies hinder market expansion, potentially limiting their widespread adoption and growth in the global market.

Request Free Customization of this report to help us to meet your business objectives.

Gene Amplification Technologies Market Competitive Landscape

The global gene amplification technologies market features intense competition among key players striving to innovate and capture market share. Established companies like Thermo Fisher Scientific, Illumina, and QIAGEN continue to dominate, leveraging their extensive R&D capabilities and diverse product portfolios. Meanwhile, emerging players such as Bio-Rad Laboratories and Agilent Technologies are rapidly gaining ground through disruptive advancements and strategic collaborations. The market's trajectory is shaped by ongoing technological advancements, increasing demand for personalized medicine, and a growing focus on genetic research across pharmaceutical, biotech, and academic sectors, driving players to continually enhance their offerings to maintain a competitive edge.

Gene Amplification Technologies Market Top Player’s Company Profiles

  • Thermo Fisher Scientific (USA)
  • Roche Diagnostics (Switzerland)
  • Agilent Technologies (USA)
  • QIAGEN (Netherlands)
  • Bio-Rad Laboratories (USA)
  • Illumina (USA)
  • Beckman Coulter (USA)
  • Fluidigm Corporation (USA)
  • Merck KGaA (Germany)
  • BioMérieux (France)
  • GenMark Diagnostics (USA)
  • Cepheid (USA)
  • Luminex Corporation (USA)
  • Enzo Biochem (USA)
  • Takara Bio (Japan)
  • Sysmex Corporation (Japan)
  • Promega Corporation (USA)
  • Becton, Dickinson and Company (USA)
  • DiaSorin S.p.A. (Italy)
  • Eppendorf (Germany)

Gene Amplification Technologies Market Recent Developments

  • In December 2023, NGeneBio said that the company has registered a domestic patent for its tuberculosis (TB) diagnostic technology based on next-generation sequencing (NGS) technology. The patent is the “Composition for gene amplification for detecting mycobacterium tuberculosis and determining drug resistance and its use.” 

    In January 2023, Moderna, Inc. acquired OriCiro Genomics K.K. for $85 million, who will provide expertise on cell-free DNA synthesis and amplification technologies.

  • In November 2022, a partnership between Merck, a renowned scientific and technological organisation, and Biotheus, a biotech company with headquarters in China that specialises in developing treatments for cancer and autoimmune diseases, was announced. By utilising Merck's Blazar Rodent Panel, Biotheus' turn-around-time (TAT) for characterising its cell lines decreased from approximately 60 days to 14 days.

Gene Amplification Technologies Key Market Trends

  • The global gene amplification technologies market is witnessing key trends such as rapid advancements in CRISPR-Cas9 technology, enabling precise and efficient gene editing. Growing applications in medical research, agriculture, and biotechnology are driving market expansion. Additionally, the rise of synthetic biology and personalized medicine fuels demand for gene amplification tools. Automation and high-throughput capabilities are enhancing efficiency. However, ethical and regulatory concerns regarding genetic manipulation remain challenges. Overall, the market is propelled by innovation, diverse applications, and increasing investment in genetic research, with a focus on both therapeutic and non-therapeutic applications.

Gene Amplification Technologies Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the global gene amplification technologies market is poised for significant growth, driven by expanding applications in research, diagnostics, and therapeutics. With advancements in techniques like PCR, LAMP, and NASBA, the market's value is expected to surge. Increasing demand for personalized medicine, genetic disease understanding, and infectious disease detection will fuel adoption. Additionally, rising investment in biotechnology and pharmaceutical sectors, along with supportive government initiatives, will contribute to market expansion. However, challenges such as technological complexity and ethical considerations might influence the landscape. Overall, the gene amplification technologies market is anticipated to flourish, offering innovative solutions for various biological challenges.

Report Metric Details
Market size value in 2022 USD 3.96 billion
Market size value in 2031 USD 9.34 billion
Growth Rate 10%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Technology
    • PCR, NASBA, LAMP, and others
  • End user
    • Academic & research institutions, diagnostic labs, and pharmaceutical companies
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific (USA)
  • Roche Diagnostics (Switzerland)
  • Agilent Technologies (USA)
  • QIAGEN (Netherlands)
  • Bio-Rad Laboratories (USA)
  • Illumina (USA)
  • Beckman Coulter (USA)
  • Fluidigm Corporation (USA)
  • Merck KGaA (Germany)
  • BioMérieux (France)
  • GenMark Diagnostics (USA)
  • Cepheid (USA)
  • Luminex Corporation (USA)
  • Enzo Biochem (USA)
  • Takara Bio (Japan)
  • Sysmex Corporation (Japan)
  • Promega Corporation (USA)
  • Becton, Dickinson and Company (USA)
  • DiaSorin S.p.A. (Italy)
  • Eppendorf (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Gene Amplification Technologies Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Gene Amplification Technologies Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Gene Amplification Technologies Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Gene Amplification Technologies Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Gene Amplification Technologies Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Gene Amplification Technologies Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Gene Amplification Technologies Market size was valued at USD 3.96 billion in 2022 and is poised to grow from USD 4.36 billion in 2023 to USD 9.34 billion by 2031, at a CAGR of 10% during the forecast period (2024-2031).

The gene amplification technologies market features intense competition among key players striving to innovate and capture market share. Established companies like Thermo Fisher Scientific, Illumina, and QIAGEN continue to dominate, leveraging their extensive R&D capabilities and diverse product portfolios. Meanwhile, emerging players such as Bio-Rad Laboratories and Agilent Technologies are rapidly gaining ground through disruptive advancements and strategic collaborations. The market's trajectory is shaped by ongoing technological advancements, increasing demand for personalized medicine, and a growing focus on genetic research across pharmaceutical, biotech, and academic sectors, driving players to continually enhance their offerings to maintain a competitive edge. 'Thermo Fisher Scientific (USA)', 'Roche Diagnostics (Switzerland)', 'Agilent Technologies (USA)', 'QIAGEN (Netherlands)', 'Bio-Rad Laboratories (USA)', 'Illumina (USA)', 'Beckman Coulter (USA)', 'Fluidigm Corporation (USA)', 'Merck KGaA (Germany)', 'BioMérieux (France)', 'GenMark Diagnostics (USA)', 'Cepheid (USA)', 'Luminex Corporation (USA)', 'Enzo Biochem (USA)', 'Takara Bio (Japan)', 'Sysmex Corporation (Japan)', 'Promega Corporation (USA)', 'Becton, Dickinson and Company (USA)', 'DiaSorin S.p.A. (Italy)', 'Eppendorf (Germany)'

The increasing demand for personalized medicine and advancements in biotechnology are propelling the growth of the gene amplification technologies market, as these technologies enable accurate and efficient analysis of genetic material for diagnostic and research purposes.

The gene amplification technologies market is witnessing key trends such as rapid advancements in CRISPR-Cas9 technology, enabling precise and efficient gene editing. Growing applications in medical research, agriculture, and biotechnology are driving market expansion. Additionally, the rise of synthetic biology and personalized medicine fuels demand for gene amplification tools. Automation and high-throughput capabilities are enhancing efficiency. However, ethical and regulatory concerns regarding genetic manipulation remain challenges. Overall, the market is propelled by innovation, diverse applications, and increasing investment in genetic research, with a focus on both therapeutic and non-therapeutic applications.

North America and Europe were likely the largest markets for gene amplification technologies due to their established biotechnology industries, extensive R&D capabilities, and supportive regulatory frameworks. These regions have a long history of innovation in the life sciences and biotechnology sectors.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Gene Amplification Technologies Market

Report ID: SQMIG35H2150

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE